Medical News
American
Medical News for 6 July 2019
Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations
EurekAlert! - 6 Jul 2019 06:00
(University of Texas M. D. Anderson Cancer Center) The 3-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer ...
Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients
Science Daily - 6 Jul 2019 18:34
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardi...
Targeted therapy combination improves survival in patients with advanced bowel cancer
EurekAlert! - 6 Jul 2019 06:00
(European Society for Medical Oncology) New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer.
Global
Great Britain
Indian
South Africa